Irreversible priapism during olanzapine and lithium therapy.
Jagadheesan
K
K
Thakur
Anupam
A
Akhtar
Sayeed
S
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002220:Carbamazepine / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D016651:Lithium Carbonate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D000077152:Olanzapine; D011317:Priapism / Q000139:chemically induced* / Q000188:drug therapy
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D016651:Lithium Carbonate; D002220:Carbamazepine; D000077152:Olanzapine